The Food and Drug Administration is a firm within the U.S. Department of Health and Human Services. The FDA is accountable for advancing the public health by helping to speed innovations that make medications and foods more reliable, more secure, and more budget friendly; and assisting the general public get the accurate, science-based information they need to use medications and foods to enhance their wellness. FDA nanotechnology financial investments have concentrated on allowing the company to define nanotechnology-based items; develop models for safety and security and effectiveness evaluation; and examine the actions of nanomaterials in organic systems and their effects on human health. LIMELIGHT: Formally joining the National Nanotechnology Initiative spending plan crosscut for the very first time in 2011, FDA will carry out tasks in wellness, environment, and safety to sustain the adhering to agency-wide concerns: lab and item testing capability, scientific staff growth and training, and interdisciplinary and collaborative research to deal with product characterization and safety and security. The objective of KHI is to advance scientific understanding of the kidney wellness and patient security implications of existing and new medical products and to foster advancement of therapies for diseases that influence the kidney by producing a collective environment in which FDA and the greater nephrology community can communicate to enhance analysis of drugs, devices, biologics, and food items. KHI tasks rely on the engagement and sweat equity of KHI members to generate the job deliverables, however subscription is not a need for involvement in KHI workgroups. The intent is that the white paper might act as a roadmap for future KHI tasks that will be produced by the KHI members. 88-15: AVAILABILITY OF U.S. FOOD AND DRUG ADMINISTRATION -APPROVED POTASSIUM IODIDE FOR USE IN EMERGENCIES INVOLVING RADIOACTIVE IODINE Addressees: Medical, Academic, and Commercial licensees that have radioactive iodine. Function: This notice is meant to provide info on the storage and use of potassium iodide as a thyroid obstructing agent in events entailing exposure to radioactive iodine. Description of Circumstances: During a nuclear pharmacy evaluation, NRC and the licensee discussed the opportunity of maintaining a supply of potassium iodide at each pharmacy location. There is an NRC and Federal Emergency Management Agency plan attending to on-site storage of FDA-approved "radiation emergency potassium iodide" as a thyroid obstructing agent for power reactor emergency situation workers. IN 88-15 April 18, 1988 Page 2 of 3 The FDA has assessed the radiological and clinical risks of carrying out potassium iodide for thyroid obstructing under emergency situation problems.
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions
** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.